Donald Trump says “everything is falling” as he argues that inflation, oil prices and other costs are moving in the right direction. David Pakman examines the distinction between inflation slowing and ...

What happens when artificial intelligence systems start to think for themselves, make themselves more powerful and escape human control in their quest to achieve superintelligence? That prospect has ...

Hudson had threatened to sue Torre for defamation over his podcast’s investigations. North Carolina vs. Duke is one of the country's biggest rivalries, no matter the sport. Belichick has a chance to ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Anthropic co-founder Dario Amodei urges a deliberate slowdown in AI development, emphasizing ...

How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...

Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...

Want only the AI that hits your stack? Build an agent that tracks your companies and topics, and skips everything else. Georgia Tech researchers Zhiqi Li, Yuxuan Liao, and Bo Zhu introduce Recursive ...

Mathematicians at OpenAI showed that the Navier-Stokes equations, which describe how fluids flow, can sometimes “blow up.” But the massive result is not without controversy. On the morning of Tuesday, ...

Plus: OpenAI has paused some model work over safety concerns. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...